In this 1.5-hour episode of the podcast, we dive deep into the cutting-edge world of longevity research with Peter Fedichev, founder of Gero, and Aleksandr Sviridov. The conversation explores the intersection of physics, biology, and aging, offering fascinating insights into the current state and future potential of longevity science.
Key topics discussed include:
The application of physics tools to understand aging and the importance of a phenomenological approach
Distinguishing between reversible and irreversible aspects of aging
Challenges in biological data collection and the shift towards more quantitative approaches
The potential of large public datasets and plasma proteomics in drug discovery
Establishing a standard model of aging and identifying variables related to maximum human lifespan
The limitations of lifespan as a measure of aging and the need for more comprehensive variables
Potential interventions including pharmacological, cellular, and gene therapies
Alternative approaches such as organ replacement and cryostasis
The concept of epigenetic rejuvenation and its challenges
Peter and Aleksandr discuss the need for exceptional talent, funding, and collaboration across fields to accelerate progress in longevity research. They emphasize the importance of prevention alongside repair in addressing aging-related damage.
The episode provides listeners with a comprehensive overview of the current state of longevity science, highlighting both the challenges and the promising avenues for future research. It underscores the need for a multidisciplinary approach, combining insights from physics, biology, and data science to unlock the secrets of aging and potentially extend human healthspan.
For those interested in diving deeper into the field, the speakers recommend following experts like Matt Kaeberlein and Peter Attia for additional insights.
This episode offers a thought-provoking exploration of longevity science, suitable for both experts in the field and curious listeners looking to understand the frontier of aging research.
